HDAC9 and non-small cell lung carcinoma: CHK1, a G2 m cell cycle regulator, has been shown to play a vital role in HDAC-inhibitor-mediated cytotoxicity in NSCLC cells and CHK1 overexpression is associated with resistance to HDAC inhibition.